异动解读 | Scotiabank上调Exact Sciences目标价,精密科学盘中大涨5.05%

异动解读
25 Feb

周一盘中,精密科学(Exact Sciences)股价大涨5.05%,引发市场高度关注。

研报公司Scotiabank维持该公司目标价,由跑赢大盘评级调整为跑赢大盘评级,目标价由70美元上调至73美元。分析师认为,Exact Sciences的前景乐观,投资者纷纷买入该股,推动股价上扬。

Exact Sciences是一家美国癌症诊断公司,专注于早期癌症检测技术。其主打产品Cologuard是一款无创大便DNA检测套装,可以非常准确地检测出结直肠癌。随着人口老龄化和健康意识提高,Cologuard预计将继续保持强劲的销售增长。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10